# Gobi Partners GBA > Gobi Partners GBA is a VC fund backing Biotechnology and Medical. See 7 investments, check sizes, portfolio and contact details. Updated Aug 2026. - Type: VC Fund - Location: Central and Western, Hong Kong - Total investments: 7 - Last investment: Apr 2026 - Lead investor: 57% - Last updated: Aug 2026 - LinkedIn: https://www.linkedin.com/company/gobi-partners-gba/ - Website: http://gobi.vc Gobi Partners GBA is a VC fund in Central and Western focused on Biotechnology and Medical. Gobi Partners GBA is part of the Pan-Asian venture capital platform Gobi Partners. Gobi GBA is the sole general partner (GP) of the Alibaba Hong Kong Entrepreneurs Fund (AEF) as well as the AEF Greater Bay Area Fund (AEF GBA Fund) and has formed strategic partnerships with other renowned financial institutions such as HSBC and Hang Seng Bank.Gobi GBA has invested in over 70 start-ups across the Greater Bay Area and has fostered the growth of 7 unicorns including Airwallex, Amber, Animoca Brands, GoGoX, Prenetics, and more. ## Contacts 5 contacts available for Gobi Partners GBA. Shizune tracks 11 team members at Gobi Partners GBA. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/gobi-partners-gba?utm_source=investor_profile ## Round sizes | Stage | Round size | | --- | --- | | Seed | $2M–$13M | | Series A | $1.4M–$12M | ## Investment focus ### Industry | Industry | Investments | Share | | --- | --- | --- | | Biotechnology | 4 | 57% | | Medical | 2 | 29% | | Solar | 1 | 14% | | Energy | 1 | 14% | | Genetics | 1 | 14% | 13 industries tracked in total. ### Stage | Stage | Investments | Share | | --- | --- | --- | | Seed | 3 | 43% | | Series A | 2 | 29% | | Angel | 1 | 14% | | Venture - Series Unknown | 1 | 14% | ### Country | Country | Investments | Share | | --- | --- | --- | | China | 3 | 43% | | Hong Kong | 3 | 43% | ## Team | Name | Title | Investments | Profile | | --- | --- | --- | --- | | Chibo Tang | Managing Partner | 13 | https://shizune.co/investors/profile/chibo-tang | | Adam Sun | Investment | 0 | https://shizune.co/investors/profile/adam-sun-bf68 | | Angel Chau | CFO | 0 | https://shizune.co/investors/profile/angel-chau-4a04 | | Hing Cheng | Executive Director of Corporate Development | 0 | https://shizune.co/investors/profile/hing-cheng-e8c3 | | Jason Chen | COO | 0 | https://shizune.co/investors/profile/jason-chen-6dc7 | ## Investments | Company | Description | Amount | Stage | Date | Website | | --- | --- | --- | --- | --- | --- | | Luquos Energy | Luquos Energy is a renewable energy company that offers energy consulting and management services. | $12.8M | Seed | Apr 21, 2026 | | | GenEditBio | GenEditBio is a biotech company that specializes in providing curative gene editing based solutions for genetic diseases. | | Venture - Series Unknown | Sep 30, 2024 | | | Base Therapeutics | Best Bio is a developer of cell therapy products and gene therapy products. | $1.4M | Series A | Sep 12, 2024 | | | Guoke Ling Fiber | Guoke Ling Fiber focuses on technological research and industrialization of key materials for hydrogen fuel cells. Guoke offers carbon fiber base paper and carbon paper production lines. | | Seed | May 07, 2024 | | | Guoke Ling Fiber | Guoke Ling Fiber focuses on technological research and industrialization of key materials for hydrogen fuel cells. Guoke offers carbon fiber base paper and carbon paper production lines. | | Angel | Sep 19, 2023 | | | BioMed Technology Holdings | BioMed offer a comprehensive service that includes a range of sophisticated tests performed by professionals, together with an interpretation and recommendations for how to live a healthy life. | $2M | Seed | Apr 20, 2023 | | | Immuno Cure | Immuno Cure, it is a biotechnology company it is specialized in the study and creation of immunotherapies for cancer, inflammatory, and infectious disorders. | $12M | Series A | | | 7 of 7 investments shown. ## Co-investors - [Alibaba Entrepreneurs Fund](https://shizune.co/investors/profile/alibaba-entrepreneurs-fund) — VC Fund, 2 deals together - [Eagles Fund](https://shizune.co/investors/profile/eagles-fund) — VC Fund, 1 deal together - [GBA Institute of Collaborative Innovation](https://shizune.co/investors/profile/gba-institute-of-collaborative-innovation) — VC Fund, 1 deal together - [Jingjinji National Center of Technology Innovation](https://shizune.co/investors/profile/jingjinji-national-center-of-technology-innovation) — VC Fund, 1 deal together - [Kylinhall Partners](https://shizune.co/investors/profile/kylinhall-partners) — VC Fund, 1 deal together - [Oriza Holdings](https://shizune.co/investors/profile/oriza-holdings) — VC Fund, 1 deal together ## Similar investors ### Similar industry - [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund - [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund - [Global Founders Capital](https://shizune.co/investors/profile/global-founders-capital) — VC Fund ### Similar stage - [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund - [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund - [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund ### Similar country - [Alibaba Entrepreneurs Fund](https://shizune.co/investors/profile/alibaba-entrepreneurs-fund) — VC Fund - [Animoca Brands](https://shizune.co/investors/profile/animoca-brands-corporation) — VC Fund - [Gobi Partners](https://shizune.co/investors/profile/gobi-partners) — VC Fund ## Featured in investor lists - [Biotechnology Investors in Hong Kong](https://shizune.co/investors/biotechnology-investors-hong-kong) - [Biotechnology VC Funds in Hong Kong](https://shizune.co/investors/biotechnology-vc-funds-hong-kong) - [Biotech VC Funds in Hong Kong](https://shizune.co/investors/biotech-vc-funds-hong-kong) - [Hospitality Investors in Hong Kong](https://shizune.co/investors/hospitality-investors-hong-kong) - [Hospitality VC Funds in Asia](https://shizune.co/investors/hospitality-vc-funds-asia) - [Health Care VC Funds in Hong Kong](https://shizune.co/investors/health-care-vc-funds-hong-kong) ## FAQ ### What does Gobi Partners GBA invest in? Gobi Partners GBA invests primarily in Biotechnology, Medical and Solar startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio. ### What is Gobi Partners GBA's check size? Gobi Partners GBA typically joins rounds of $2M–$13M at Seed and $1.4M–$12M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Gobi Partners GBA participates in. ### How do I contact Gobi Partners GBA? Public channels for Gobi Partners GBA include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox. ### Who are the partners at Gobi Partners GBA? The team at Gobi Partners GBA includes Chibo Tang (Managing Partner), Adam Sun (Investment) and Angel Chau (CFO), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links. ### Is Shizune's investor data accurate? Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co